Leadless Pacemakers Market Size, Share & Trends Analysis Report By Chambers (Single Chamber, Dual Chamber), By Brands (Micra VR and VR2, Micra AV and AV2, Abbott Aveir DR, Abbott Aveir VR, Abbott Aveir AR), By End Use, By Region, And Segment Forecasts, 20

Leadless Pacemakers Market Summary

The global leadless pacemakers market size was estimated at USD 842.37 million in 2024 and is projected to reach USD 1,622.87 million by 2033, growing at a CAGR of 6.48% from 2025 to 2033. The increasing prevalence of cardiac disorders and associated risk factors is expected to drive demand for advanced device-based therapies.

According to an Oxford Academic article published in January 2025, globally, the age-standardized prevalence of cardiovascular disease is estimated at approximately 7,179 cases per 100,000 people, emphasizing the significant and growing burden of cardiac conditions. This high prevalence has amplified the need for innovative pacing solutions to manage rhythm disorders more safely and effectively. Leadless pacemakers have emerged as a transformative advancement in this field, offering a minimally invasive alternative to traditional pacemakers by eliminating the need for leads and surgical pockets.

Leadless pacemakers (PMs) have become a well-established therapeutic option over the past decade, offering significant advantages over traditional transvenous pacemakers. According to the NCBI article published in April 2025, eliminating leads and subcutaneous pockets, leadless devices such as Micra and Aveir substantially reduce the risk of infections and long-term complications such as electrode dislocation, pocket hematomas, pneumothorax, endocarditis, and venous obstruction. Data from the Micra PAR registry, which followed 1,809 patients for a mean of 51 months, reported a five-year major complication rate of only 4.5%, with most occurring within 30 days of implantation. Notably, no infections required device removal, and system revisions were rare, primarily for device upgrades or battery depletion.

Global Leadless Pacemakers Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global leadless pacemakers market report based on chambers, brands, end use, and region:

• Chambers Outlook (Revenue, USD Million, 2021 - 2033)
• Single Chamber
• Dual Chamber
• Brands Outlook (Revenue, USD Million, 2021 - 2033)
• Micra VR and VR2
• Micra AV and AV2
• Abbott Aveir DR
• Abbott Aveir VR
• Abbott Aveir AR
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more